DNA demethylating therapy in MDS: The experience with 5-AZA-2 '-deoxycytidine (decitabine).

Wijermans, P; Ferrant, Augustin; Luebbert, M; Verhoef, G.; Bosly, André; Ravoet, C; André, Marc; Haak, H

DNA demethylating therapy in MDS: The experience with 5-AZA-2 '-deoxycytidine (decitabine).

Wijermans, P

;

Ferrant, Augustin

;

Luebbert, M

;

Verhoef, G.

;

Haak, H

;et.al.

(1999)

Files

No attached file found for this publication.

Details

Authors

Wijermans, P
Author
Ferrant, AugustinUCLouvain
Author
Luebbert, M
Author
Verhoef, G.
Author
Bosly, AndréUCLouvain
Author
Haak, H
Author

Affiliations

UCLouvainCliniques universitaires Saint-Luc
UCLouvain

Citations

APA
Chicago
FWB

Wijermans, P., Ferrant, A., Luebbert, M., Verhoef, G., Bosly, A., Ravoet, C., André, M., & Haak, H. (1999). DNA demethylating therapy in MDS: The experience with 5-AZA-2 ’-deoxycytidine (decitabine). Blood, 94(10), 306A-306A. (Original work published 1999)